Literature DB >> 7937974

Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody.

M Haraguchi1, S Yamashiro, A Yamamoto, K Furukawa, K Takamiya, K O Lloyd, H Shiku, K Furukawa.   

Abstract

For the isolation of ganglioside GD3 synthase (EC 2.4.99.8) cDNA, we developed an expression cloning approach that used an anti-GD2 monoclonal antibody for selection. A host recipient cell line that we have named KF3027-Hyg5 was also utilized. This cell line expresses high levels of GM2 as well as GM3 but no GD3 or GD2 and was constructed from mouse B16 melanoma cells transfected with the polyoma large tumor antigen gene (KF3027) and the previously cloned beta-1,4-N-acetylgalactosaminyltransferase (EC 2.4.1.92) cDNA. Four rounds of transfection, monoclonal antibody 3F8 panning, and Hirt extraction resulted in the isolation of two cDNA clones, transfection of which directed the expression of GD3 in KF3027 and B16 melanoma cells and GD3 and GD2 in KF3027-Hyg5 cells. The cDNA contained a 1650-bp insert and a single open reading frame. The deduced amino acid predicted a type II membrane topology consisting of cytoplasmic (14 aa), transmembrane (18 aa), and catalytic (309 aa) domains. The sequence also predicted the presence of a sialyl motif similar to that found in the other sialyltransferases cloned so far. As expected, mRNA of this gene (2.6 kb) was strongly expressed in human melanoma lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937974      PMCID: PMC45039          DOI: 10.1073/pnas.91.22.10455

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  CHROMATOGRAPHIC SEPARATION OF HUMAN BRAIN GANGLIOSIDES.

Authors:  L SVENNERHOLM
Journal:  J Neurochem       Date:  1963-09       Impact factor: 5.372

2.  Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3.

Authors:  P Hersey; S D Schibeci; P Townsend; C Burns; D A Cheresh
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

3.  Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

Authors:  N K Cheung; U M Saarinen; J E Neely; B Landmeier; D Donovan; P F Coccia
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

4.  A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.

Authors:  E J Natoli; P O Livingston; C S Pukel; K O Lloyd; H Wiegandt; J Szalay; H F Oettgen; L J Old
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

5.  Differential expression of ganglioside GD3 by human leukocytes and leukemia cells.

Authors:  B Siddiqui; J Buehler; M W DeGregorio; B A Macher
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

6.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

7.  Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies.

Authors:  W D Merritt; J T Casper; S J Lauer; G H Reaman
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

8.  Gene-regulated expression of glycolipids: appearance of GD3 ganglioside in rat cells on transfection with transforming gene E1 of human adenovirus type 12 DNA and its transcriptional subunits.

Authors:  H Nakakuma; Y Sanai; K Shiroki; Y Nagai
Journal:  J Biochem       Date:  1984-11       Impact factor: 3.387

9.  Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants.

Authors:  K Furukawa; H Clausen; S Hakomori; J Sakamoto; K Look; A Lundblad; M J Mattes; K O Lloyd
Journal:  Biochemistry       Date:  1985-12-17       Impact factor: 3.162

10.  Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.

Authors:  B Seed; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more
  60 in total

Review 1.  Synthesis of oligosaccharides by bacterial enzymes.

Authors:  K F Johnson
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

Review 2.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

3.  Triptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cells.

Authors:  Haw-Young Kwon; Seok-Jo Kim; Cheorl-Ho Kim; Sung-Wook Son; Kyoung-Sook Kim; Jai-Heon Lee; Su-Il Do; Young-Choon Lee
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

4.  CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.

Authors:  H Voigt; D Schrama; A O Eggert; C S Vetter; K Müller-Blech; H M Reichardt; M H Andersen; J C Becker; F Lühder
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 5.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

6.  Large-scale expression of recombinant sialyltransferases and comparison of their kinetic properties with native enzymes.

Authors:  M A Williams; H Kitagawa; A K Datta; J C Paulson; J C Jamieson
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

7.  Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells.

Authors:  M A Recchi; A Harduin-Lepers; Y Boilly-Marer; A Verbert; P Delannoy
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

8.  T cell homeostatic proliferation elicits effective antitumor autoimmunity.

Authors:  Wolfgang Dummer; Andreas G Niethammer; Roberto Baccala; Brian R Lawson; Norbert Wagner; Ralph A Reisfeld; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.

Authors:  Zachary S Morris; Emily I Guy; David M Francis; Monica M Gressett; Lauryn R Werner; Lakeesha L Carmichael; Richard K Yang; Eric A Armstrong; Shyhmin Huang; Fariba Navid; Stephen D Gillies; Alan Korman; Jacquelyn A Hank; Alexander L Rakhmilevich; Paul M Harari; Paul M Sondel
Journal:  Cancer Res       Date:  2016-05-06       Impact factor: 12.701

10.  Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.

Authors:  Assefa Wondimu; Tianqian Zhang; Thomas Kieber-Emmons; Phyllis Gimotty; Katrin Sproesser; Rajasekharan Somasundaram; Soldano Ferrone; Chun-Yen Tsao; Dorothee Herlyn
Journal:  Cancer Immunol Immunother       Date:  2008-07       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.